Unveiling the role of Monkeypox (Mpox) Virus A23 protein in human cells

Mpox News: The Rising Threat of Monkeypox
Monkeypox virus (MPXV) has emerged as a significant public health concern, with its ability to infect both humans and wildlife. First identified in 1958 among macaques in Singapore, the virus has since spread globally, causing over 79,000 reported cases by December 2022. The recent global outbreak in 2022 highlighted the virus's potential for widespread transmission, leading the World Health Organization (WHO) to declare it a public health emergency of international concern. This Mpox News report focuses on a recent study conducted by researchers from the Jiangxi Agricultural University-China, who explored the intricate mechanisms through which MPXV interacts with human cells, specifically examining the A23 protein of the virus. Their findings shed light on potential new therapeutic targets to combat MPXV infections.


Unveiling the role of Monkeypox (Mpox) Virus A23 protein in human cells

Understanding Monkeypox Virus: Structure and Components
Before delving into the study, it is crucial to understand the structure of the Monkeypox virus, which is a member of the Orthopoxvirus genus in the Poxviridae family. MPXV is a double-stranded DNA virus with a complex structure, comprising three main components: the core, the envelope, and the lateral bodies. Each of these components houses specific viral proteins that play vital roles in the virus's lifecycle.
 
-Core: The core of MPXV contains the viral DNA and essential enzymes required for the replication of the viral genome. The DNA is tightly packed within a dumbbell-shaped core, surrounded by a protein matrix. Some of the key proteins found in the core include the DNA-dependent RNA polymerase, which is essential for transcribing viral genes, and the topoisomerase, which helps in the unwinding of DNA strands during replication. The A23 protein, the focus of this study, belongs to a group of proteins associated with viral replication and DNA processing. Specifically, the A23 protein is involved in resolving DNA structures during viral replication, making it a crucial component of the virus’s replication machinery.
 
-Envelope: Surrounding the core is a lipid bilayer envelope, which is derived from the host cell's membrane. The envelope is embedded with viral proteins that are crucial for the virus's ability to infect host cells. These proteins facilitate the attachment of the virus to the host cell surface, initiating the infection process. Key envelope proteins include the M1R and H3L proteins, which mediate the fusion of the viral envelope with the host cell membrane, allowing the viral core to enter the host cell. Another important envelope protein is the B5R, which plays a role in the release of newly formed viral particles from infected cells.
 
-Lateral Bodies: Positioned on either side of the core are the lateral bodies, which contain additional proteins that play a role in the early stages of infection. These proteins are released into the host cell soon after infection, helping to modulate the host's immune response and facilitate the replication of the virus. Examples of proteins found in the lateral bodies include the F13L protein, which is involved in the formation of the viral envelope, and the A33R protein, which helps in the spread of the virus from cell to cell.
 
The combination of these three components, along with their associated proteins, makes MPXV a formidable pathogen, capable of evading the host's immune system and establishing a successful infection.
 
The Study: Combining Transcriptomics and Proteomics
The study team conducted a high-throughput analysis to unravel the effects of the A23 protein on human cells. The study, utilized advanced techniques such as RNA sequencing (RNA-seq) and liquid chromatography-tandem mass spectrometry (LC-MS/MS) to study the transcriptional and metabolic responses in HEK293T cells - a commonly used human cell line in research.
 
This study aimed to explore the interactions between the A23 protein of MPXV and the host cell's proteins, providing insights into how this protein might contribute to the virus's ability to replicate and evade the host immune system.
 
Key Findings: A Complex Interplay of Viral and Host Proteins
The researchers discovered that the transfection of MPXV A23 protein into HEK293T cells resulted in significant changes in gene expression. Specifically, they identified 648 differentially expressed genes (DEGs), with 314 genes being upregulated and 334 downregulated. This substantial alteration in gene expression suggests that the A23 protein plays a pivotal role in manipulating the host cell's environment to favor viral replication.
 
In addition to the transcriptomic analysis, the study revealed that the A23 protein primarily interacted with ribosomal proteins and histones within the host cells. This interaction is particularly significant as it indicates that the A23 protein may be hijacking the host's protein synthesis machinery to produce viral proteins. Moreover, the interaction with histones suggests that the A23 protein could be altering the host's chromatin structure, thereby modulating gene expression to facilitate viral replication.
 
This study also identified a nuclear localization signal (NLS) sequence within the A23 protein, specifically the RKKR sequence at amino acids 123–126, which allows the protein to enter the nucleus of the host cell. Once inside the nucleus, the A23 protein can interact with the host's genetic material, further influencing gene expression and aiding in the virus's replication process.
 
The Role of A23 Protein in Host Immune Evasion
The study's findings suggest that the MPXV A23 protein plays a multifaceted role in the virus's ability to evade the host's immune system. The interaction between the A23 protein and the host's ribosomal proteins points to a potential mechanism by which the virus can enhance its replication efficiency. By co-opting the host's protein synthesis machinery, the virus can produce the necessary proteins for its replication while simultaneously suppressing the host's immune response.
 
Moreover, the interaction with histones and the presence of a nuclear localization signal within the A23 protein indicate that this protein may be involved in altering the host's chromatin structure. By modifying the organization of chromatin, the virus can influence which genes are expressed in the host cell, potentially turning off genes involved in antiviral responses while upregulating those that favor viral replication.
 
The suppression of host immune responses is a common strategy among viruses, and MPXV appears to be no exception. The study's findings highlight the potential of the A23 protein to act as an immune evasion tool, helping the virus to establish a successful infection and spread within the host.
 
Implications for Therapeutic Development
The identification of the A23 protein's interactions with host cell proteins opens up new avenues for therapeutic development. By targeting the A23 protein or its interactions with host cell proteins, it may be possible to disrupt the virus's ability to replicate and spread, providing a new strategy for combating MPXV infections.
 
One potential approach could involve the development of small molecules or peptides that specifically inhibit the interaction between the A23 protein and ribosomal proteins or histones. By preventing these interactions, it may be possible to halt the virus's replication process and reduce the severity of the infection.
 
Another approach could involve the use of gene editing technologies, such as CRISPR-Cas9, to disrupt the nuclear localization signal within the A23 protein. By preventing the protein from entering the nucleus, it may be possible to limit its ability to modulate host gene expression, thereby reducing the virus's ability to replicate and evade the immune system.
 
Conclusion: A Step Forward in Understanding Monkeypox Virus
The study conducted by the research team at Jiangxi Agricultural University represents a significant step forward in understanding the molecular mechanisms underlying MPXV infections. By shedding light on the role of the A23 protein in modulating host cell processes, this research provides valuable insights into how the virus replicates and evades the immune system.
 
These findings have important implications for the development of new therapeutic strategies against MPXV. By targeting the A23 protein and its interactions with host cell proteins, it may be possible to disrupt the virus's ability to replicate and spread, ultimately leading to more effective treatments for MPXV infections.
 
The study findings were published in the peer-reviewed International Journal of Molecular Sciences.
https://www.mdpi.com/1422-0067/25/16/8678
 
For the latest Mpox News, keep on logging to Thailand Medical News.
 
Read Also:
https://www.thailandmedical.news/news/new-insights-into-understanding-mpox-s-evasion-of-the-immune-system
 
 https://www.thailandmedical.news/news/u-s-nih-finds-that-tecovirimat-the-mpox-drug-many-countries-were-stockpiling-is-not-effective-against-the-new-clade-1-strain
 
https://www.thailandmedical.news/news/clinically-used-anti-hpv-agent-shows-promise-in-preventing-sexual-transmission-of-mpox